Vaidya Sane Ayurved Laboratories Limited

As of March 31, 2026, Vaidya Sane Ayurved Laboratories Limited carries a market capitalization of 1.75B, placing it among publicly traded companies globally. Its enterprise value stands at 1.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Vaidya Sane Ayurved Laboratories Limited has 10.51M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Vaidya Sane Ayurved Laboratories Limited maintains a current ratio of 3.99, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Vaidya Sane Ayurved Laboratories Limited's stock has declined approximately 43.02% over the past 52 weeks. The 50-day moving average sits at 169.05, while the 200-day moving average is 207.89.

As of March 31, 2026, Vaidya Sane Ayurved Laboratories Limited holds 230.65M in cash and equivalents against 25.85M in total debt, resulting in a net debt position of 21.48M. Total book value stands at 872.95M, with working capital of 331.99M providing operational flexibility.